首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2953篇
  免费   70篇
  国内免费   288篇
化学   2898篇
晶体学   18篇
力学   5篇
综合类   1篇
数学   19篇
物理学   370篇
  2024年   13篇
  2023年   91篇
  2022年   13篇
  2021年   33篇
  2020年   38篇
  2019年   75篇
  2018年   68篇
  2017年   76篇
  2016年   75篇
  2015年   68篇
  2014年   112篇
  2013年   181篇
  2012年   127篇
  2011年   183篇
  2010年   157篇
  2009年   200篇
  2008年   166篇
  2007年   212篇
  2006年   215篇
  2005年   237篇
  2004年   220篇
  2003年   92篇
  2002年   55篇
  2001年   74篇
  2000年   78篇
  1999年   54篇
  1998年   54篇
  1997年   45篇
  1996年   44篇
  1995年   43篇
  1994年   30篇
  1993年   29篇
  1992年   24篇
  1991年   27篇
  1990年   26篇
  1989年   9篇
  1988年   15篇
  1987年   12篇
  1986年   11篇
  1985年   3篇
  1984年   10篇
  1983年   1篇
  1982年   4篇
  1981年   1篇
  1980年   4篇
  1979年   3篇
  1977年   1篇
  1976年   1篇
  1974年   1篇
排序方式: 共有3311条查询结果,搜索用时 15 毫秒
101.
β-三氟甲基-β甲氧基β-苯基乙胺(TMPEA)是含氨基功能团的手性试剂[1].由于胺可将按酸转变成酸胺,该试剂已成功地用于手性有机酸对映体的纯度测定[2].考虑到胺同样可将醛酮转变成亚胺,本文进一步探讨了TMPEA用于手性醒酮对映体纯度测定的可行性.用R-(-)-TMPEA及dl-TMPAE分别与下列4种手性酮反应,制备相应的非对映异构亚胶:比较光活亚胺及相应的非对映异构体混合物亚腔的NMR谱,可确定各组非对映异构亚胺‘HNMR位移差(以OCH为探针基团)和’‘FNMR的位移差(以CF为探针基团)(表1).TablelCheffiicalshif…  相似文献   
102.
Lin X  Zhu C  Hao A 《Electrophoresis》2005,26(20):3890-3896
The resolving ability of 2-O-(2-hydroxybutyl)-beta-CD (HB-beta-CD) with different degrees of substitution (DS = 2.9 and 4.0) as a chiral selector in CZE is reported in this work. Fourteen chiral drugs belonging to different classes of compounds of pharmaceutical interest such as beta-agonists, antifungal agents, ageneric agents, etc., were resolved. The effects of the DS of HB-beta-CD on separations were also investigated. The chiral resolution (R(s)) was strongly influenced by the concentrations of the CD derivative, the BGE, and the pH of the BGE. Under the conditions of 50 mmol/L Tris-phosphate buffer at pH 2.5 containing 5 mmol/L HB-beta-CD, all 14 analytes were separated. The very low concentration necessary to obtain separation was particularly impressive. The DS had a significant effect on the resolution of the chiral drugs and the ionic strength of the separation media; hence, the use of a well-characterized CD derivative is crucial.  相似文献   
103.
Summary A method is described for the determination of the enantiomeric purity (enantiomeric excess) of the anticholinergic drug oxyphenonium. The method for this quaternary ammonium compound is based on the direct HPLC analysis with a chiral stationary phase. Two kinds of 1-acid glycoprotein-bonded phases were used.For the detection a post-column extraction with fluorescence detection of the ion-pair counter ion dimethoxyantracene sulphonate was used.  相似文献   
104.
符合经典构效关系的抗肿瘤铂类药物   总被引:3,自引:0,他引:3  
王联红  刘芸  苟少华  尤启冬 《化学通报》2003,66(12):828-836
综述了自顺铂、卡铂后符合经典构效关系的铂类抗肿瘤药物的发展概况,按载体配基和离去基团的结构特征进行了分类,总结了各类配合物的构效关系和临床进展,其中重点对手性二胺配体的铂(Ⅱ)配合物进行了介绍。并讨论了顺铂、卡铂、奥沙利铂的作用机理。  相似文献   
105.
Summary Capillary electrophoresis has been used for the chiral analysis of two -amino alcohol pharmaceutical compounds. Capillary zone electrophoresis conditions were used with -cyclodextrin as a chiral mobile phase additive. The effects of variation of -cyclodextrin concentration, temperature, pH, background electrolyte composition and concentration have been investigated. Optimum separations were achieved for clenbuterol using -cyclodextrin at its solubility limit (16mM), the lowest practicable temperature (19°C), pH 4.0 and an electrolyte solution with a high ionic strength prepared from 0.1 M citric acid and 0.3 M Na2HPO4. For the development compound picumeterol and its (S)-enationmer, the optimum pH 4.0 buffer was prepared from 0.1 M citric acid and 0.2 M sodium acetate. Baseline separation with resolution greater than 2 was achieved for both compounds.This work was presented in part at the 2nd International Symposium on Chiral Discrimination, Rome, May 27–31, 1991.  相似文献   
106.
重点报道了以(1R,2S)或(1S,2R)-1,2-二苯基-2-氨基乙醇衍生物手性配体的合成及其用于不对称催化反应的研究,如去氢氨基酸的氢化、醛的乙基锌加成、酮的还原、活泼亚甲基化合物的烷基化、醛的硅腈化和瑞福马斯基反应等.研究了手性配体的结构、底物和反应条件等对上述反应的对映选择性和催化活性的影响.  相似文献   
107.
Four new chiral stationary phases based on mono-(6A-allylcarbamido-6A-deoxy)-arylcarbamoylated β-cyclodextrin were synthesized. The chiral stationary phase of phenylcarbamoylated β-cyclodextrin exhibited excellent separation capability for a variety of chiral compounds. Compared with the previous work, it was found that the spacer remained on the surface of the silica gel and decreased the enantioseparation capability.  相似文献   
108.
A new pyrenemethylamine substituted l-Boc-tyrosine derivative was synthesized and characterized. UV-vis, FL, CD, and light scattering experiments proved that the chiral molecules were able to self-assemble for formation of new aggregate structure. The SEM and AFM images indicated that the helical wires could be fabricated by π-π stacking interaction between adjacent pyrene molecules.  相似文献   
109.
《Tetrahedron》2004,60(4):885-891
threo and erythro diastereoisomers of the constrained amino acid (βMe)Phe can be obtained separately on a multigram scale through a three-step synthesis from the corresponding Z and E isomers of 2-phenyl-4(α-phenylethylidene)-5(4H)-oxazolone. The 5(4H)-oxazolones are readily available from acetophenone and hippuric acid. The four enantiomerically pure isomers of β-methylphenylalanine, (2R,3R)-(βMe)Phe, (2S,3S)-(βMe)Phe, (2R,3S)-(βMe)Phe and (2S,3R)-(βMe)Phe, have been prepared by HPLC resolution of the racemic precursors methyl threo (or erythro)-2-benzamide-3-phenylbutanoates.  相似文献   
110.
Mono(6-(p-toluenesulfonyl))permethylated β-cyclodextrin, a versatile precursor for a wide variety of mono-functionalized permethyl β-cyclodextrins, has been generated successfully by the direct methylation of monotosylated cyclodextrin. This afforded a convenient synthesis of mono(6A-N-allylamino-6A-deoxy)permethylated β-cyclodextrin. Hydrosilylation of the chiral selector with (EtO)3SiH and reaction of the resultant reactive siloxane with pristine silica gel afforded a facile entry into a structurally well-defined chiral HPLC stationary phase.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号